Bellevue Global Life Science Investors LLC 13D and 13G filings for Bellevue Life Sciences Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 9:03 pm Unchanged | 2024-12-31 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC | Bellevue Global Life Science Investors LLC | 2,035,000 87.700% | 0 (Unchanged) | Filing |
| 2024-08-14 08:00 am Unchanged | 2024-06-30 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC | Bellevue Global Life Science Investors LLC | 2,035,000 50.400% | 0 (Unchanged) | Filing |
| 2024-02-08 4:20 pm Purchase | 2023-12-31 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC | Bellevue Global Life Science Investors LLC | 2,035,000 36.200% | 2,035,000 (New Position) | Filing |